Deutsche Bank’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.82M | Sell |
435,359
-11,171
| -3% | -$156K | ﹤0.01% | 1155 |
|
|
2026
Q1 | $4.21M | Buy |
446,530
+21,716
| +5% | +$238K | ﹤0.01% | 1387 |
|
|
2025
Q4 | $5.28M | Buy |
424,814
+66,405
| +19% | +$883K | ﹤0.01% | 1280 |
|
|
2025
Q3 | $5.14M | Buy |
358,409
+128,852
| +56% | +$1.77M | ﹤0.01% | 1294 |
|
|
2025
Q2 | $2.82M | Buy |
229,557
+127,760
| +126% | +$1.86M | ﹤0.01% | 1512 |
|
|
2025
Q1 | $2.24M | Sell |
101,797
-243,681
| -71% | -$5.73M | ﹤0.01% | 1674 |
|
|
2024
Q4 | $7.84M | Buy |
345,478
+163,290
| +90% | +$3.56M | ﹤0.01% | 1120 |
|
|
2024
Q3 | $3.31M | Buy |
182,188
+127,479
| +233% | +$2.95M | ﹤0.01% | 1471 |
|
|
2024
Q2 | $1.59M | Buy |
54,709
+22,674
| +71% | +$672K | ﹤0.01% | 1749 |
|
|
2024
Q1 | $1.14M | Sell |
32,035
-23,691
| -43% | -$948K | ﹤0.01% | 1960 |
|
|
2023
Q4 | $2.43M | Buy |
55,726
+27,584
| +98% | +$1.09M | ﹤0.01% | 1579 |
|
|
2023
Q3 | $1.07M | Buy |
28,142
+23,734
| +538% | +$999K | ﹤0.01% | 1676 |
|
|
2023
Q2 | $181K | Sell |
4,408
-287
| -6% | -$13.8K | ﹤0.01% | 2944 |
|
|
2023
Q1 | $270K | Buy |
4,695
+135
| +3% | +$7.61K | ﹤0.01% | 2852 |
|
|
2022
Q4 | $256K | Sell |
4,560
-21,296
| -82% | -$1.08M | ﹤0.01% | 2828 |
|
|
2022
Q3 | $1.09M | Buy |
25,856
+21,703
| +523% | +$1.11M | ﹤0.01% | 1907 |
|
|
2022
Q2 | $225K | Sell |
4,153
-537
| -11% | -$32.3K | ﹤0.01% | 3096 |
|
|
2022
Q1 | $302K | Buy |
4,690
+233
| +5% | +$15.3K | ﹤0.01% | 3039 |
|
|
2021
Q4 | $298K | Sell |
4,457
-1,922
| -30% | -$130K | ﹤0.01% | 3157 |
|
|
2021
Q3 | $437K | Buy |
6,379
+235
| +4% | +$16.6K | ﹤0.01% | 3133 |
|
|
2021
Q2 | $419K | Sell |
6,144
-2,399
| -28% | -$170K | ﹤0.01% | 3332 |
|
|
2021
Q1 | $589K | Buy |
8,543
+2,275
| +36% | +$154K | ﹤0.01% | 3002 |
|
|
2020
Q4 | $408K | Sell |
6,268
-68,086
| -92% | -$3.66M | ﹤0.01% | 3041 |
|
|
2020
Q3 | $3.51M | Sell |
74,354
-65,069
| -47% | -$3.1M | ﹤0.01% | 1425 |
|
|
2020
Q2 | $6.55M | Buy |
139,423
+15,010
| +12% | +$738K | 0.01% | 1166 |
|
|
2020
Q1 | $5.56M | Buy |
124,413
+112,346
| +931% | +$5.9M | 0.01% | 1198 |
|
|
2019
Q4 | $701K | Sell |
12,067
-28,719
| -70% | -$1.71M | ﹤0.01% | 2564 |
|
|
2019
Q3 | $2.45M | Sell |
40,786
-32,359
| -44% | -$1.93M | ﹤0.01% | 1789 |
|
|
2019
Q2 | $4.08M | Buy |
73,145
+51,855
| +244% | +$2.67M | ﹤0.01% | 1938 |
|
|
2019
Q1 | $1.18M | Sell |
21,290
-115,868
| -84% | -$5.9M | ﹤0.01% | 2877 |
|
|
2018
Q4 | $6.18M | Sell |
137,158
-221,881
| -62% | -$12.2M | ﹤0.01% | 1609 |
|
|
2018
Q3 | $23.6M | Buy |
359,039
+146,096
| +69% | +$9.08M | 0.01% | 1042 |
|
|
2018
Q2 | $13.7M | Sell |
212,943
-264,768
| -55% | -$16.4M | 0.01% | 1470 |
|
|
2018
Q1 | $26.4M | Buy |
477,711
+188,523
| +65% | +$9.88M | 0.01% | 959 |
|
|
2017
Q4 | $13.8M | Buy |
289,188
+33,598
| +13% | +$1.64M | 0.01% | 1249 |
|
|
2017
Q3 | $12.9M | Buy |
255,590
+89,302
| +54% | +$4.59M | 0.01% | 1280 |
|
|
2017
Q2 | $9.06M | Buy |
166,288
+9,993
| +6% | +$477K | 0.01% | 1472 |
|
|
2017
Q1 | $6.58M | Buy |
156,295
+539
| +0.3% | +$23K | ﹤0.01% | 1525 |
|
|
2016
Q4 | $6.68M | Sell |
155,756
-194,762
| -56% | -$7.92M | 0.01% | 1504 |
|
|
2016
Q3 | $14.5M | Sell |
350,518
-389,232
| -53% | -$16.3M | 0.01% | 1072 |
|
|
2016
Q2 | $29.5M | Sell |
739,750
-419,274
| -36% | -$15.1M | 0.02% | 732 |
|
|
2016
Q1 | $39M | Buy |
1,159,024
+579,834
| +100% | +$18.1M | 0.03% | 608 |
|
|
2015
Q4 | $19.6M | Sell |
579,190
-7,226
| -1% | -$226K | 0.01% | 924 |
|
|
2015
Q3 | $17.5M | Buy |
586,416
+4,672
| +0.8% | +$146K | 0.01% | 966 |
|
|
2015
Q2 | $16M | Sell |
581,744
-87,645
| -13% | -$2.34M | 0.01% | 1053 |
|
|
2015
Q1 | $16.9M | Buy |
669,389
+206,186
| +45% | +$4.87M | 0.01% | 1020 |
|
|
2014
Q4 | $10.3M | Buy |
463,203
+59,220
| +15% | +$1.2M | 0.01% | 1410 |
|
|
2014
Q3 | $8.2M | Buy |
403,983
+59,642
| +17% | +$1.19M | 0.01% | 1500 |
|
|
2014
Q2 | $6.62M | Buy |
344,341
+34,982
| +11% | +$652K | ﹤0.01% | 1624 |
|
|
2014
Q1 | $5.82M | Buy |
309,359
+41,453
| +15% | +$800K | ﹤0.01% | 1703 |
|
|
2013
Q4 | $5.22M | Sell |
267,906
-28,482
| -10% | -$522K | ﹤0.01% | 1734 |
|
|
2013
Q3 | $4.87M | Sell |
296,388
-635,329
| -68% | -$10.2M | ﹤0.01% | 1845 |
|
|
2013
Q2 | $13.9M | Buy |
+931,717
| New | +$13.7M | 0.01% | 1052 |
|
Other funds holding IART
RCMNY
PCMI
Deutsche Bank's IART Position: Q2 2026 in Review
Deutsche Bank reduced its Integra LifeSciences (IART) stake by 2.5% in Q2 2026, selling an estimated $156K and leaving 435,359 shares worth $7.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1155.
Deutsche Bank first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $39M in Q1 2016. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Deutsche Bank held 435,359 shares of Integra LifeSciences worth $7.82M as of Q2 2026.
- Deutsche Bank sold 11,171 Integra LifeSciences shares in Q2 2026, an estimated $156K.
- Integra LifeSciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1155 holding.
- Deutsche Bank first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Integra LifeSciences position peaked at $39M in Q1 2016.
- 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.